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ABSTRACT | Ocular adnexal involvement in CD30+ lympho-
proliferative disorders is rare. We report the case of a 73-year-old 
woman with a relapsing primary cutaneous anaplastic large cell 
lymphoma on her eyelid. A systemic extension study excluded 
extracutaneous involvement. Systemic chemotherapy resulted in 
an optimal response, with complete regression of the cutaneous 
lesions. There has been no recurrence during the 2 years of 
follow-up.
Keywords: Eyelid neoplasms; Lymphoma, primary cutaneous 
anaplastic large cell; Lymphoma, T-cell, cutaneous; Case reports
RESUMO | O acometimento ocular adicional nos distúrbios 
linfoproliferativos CD30+ é raro. Relatamos o caso de uma mulher 
de 73 anos com linfoma de grandes células anaplásicas primárias 
recidivantes em sua pálpebra. A avaliação sistêmica excluiu en-
volvimento extracutâneo. A quimioterapia sistémica resultou em 
uma resposta ótima, com regressão completa das lesões cutáneas. 
Não houve recidiva durante 2 anos de acompanhamento.
Descritores: Neoplasias palpebrais; Linfoma anaplásico cutâ-
neo primário de células grandes; Linfoma cutâneo de células T; 
Relatos de casos
INTRODUCTION
CD30+ lymphoproliferative disorders are type T 
lymphomas. They are characterized by large, anaplas-
tic morphology and the CD30+ immunophenotype of 
tumoral cells and include lymphomatous papulosis, 
anaplastic large cell primary cutaneous lymphoma, and 
anaplastic large cell systemic lymphoma. Eyelid invol-
vement in anaplastic large cell lymphoma is rare and 
usually appears secondary to systemic anaplastic large 
cell lymphoma.
CASE REPORT
A 73-year-old woman presented with a multinodular 
lesion in her right upper eyelid that had grown slowly 
over the previous 8 weeks. Examination showed diffuse 
eyelid edema and redness. In addition, there were five 
erythematous subcutaneous nodules firmly adhered to 
deep planes, one of them located on the eyelid margin, 
another with central ulceration, and a medial nodule 
with ulceration and secondary hyperkeratosis (Figure 1). 
An ophthalmic examination revealed mechanical ptosis 
secondary to palpebral involvement, with preserved 
visual acuity. An intraocular pressure test, fundus exa-
mination, and test of extraocular motility revealed no 
pathologic findings. Examination results for the other 
eye were all within the normal range.
The patient’s previous medical history included an 
anaplastic large cell primary cutaneous lymphoma on 
her lower limb. This had relapsed locally following 
first-line therapy with R-CHOP administered two years 
ago (Figure 2).
A CT scan revealed a circumscribed hyperdense eye-
lid mass, 15 × 7 mm in size, which did not compromise 
the eye; no orbital lesions were observed. An incisional 
biopsy of the lesion and a systemic extension study were 
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performed. The anatomopathological study revealed 
pseu doepitheliomatous epidermal hyperplasia associa-
ted with giant atypical cells and dermic tumoral infil-
trate that was positive for CD30 and CD45 and negative 
for CD20, CD3, CD2, CD5, CD8, CD7, AE1/AE3, S100, 
EMA, and ALK (Figure 3). The systemic extension study 
ruled out extracutaneous involvement. The diagnosis was 
mul tifocal primary cutaneous large cell anaplastic lym-
phoma, with a TNM stage of T3aN0M0.
Second-line systemic chemotherapy (six cycles of na-
velbine and gemcitabine) achieved complete regression 
of the eyelid and limb lesions (Figure 4). After two years, 
the patient remains in complete remission.
DISCUSSION
Lymphomas are the most common type of ocular ad-
nexal neoplasia, affecting the conjunctiva, lacrimal gland, 
eyelids, and orbital tissues. Non-Hodgkin B lymphomas 
account for more than 90% of adnexal ocular lympho-
mas, whereas only 1%-2% exhibit the T immunopheno-
type(1,2). A great many studies have focused on the most 
common subtypes. In order of frequency, these are mu-
cosa-associated lymphoid tissue lymphoma, follicular 
lymphoma, giant cell diffuse B lymphoma, and mantle 
cell lymphoma. Studies of the uncommon subtypes have 
been scarce and describe either small groups within 
larger series of B lymphomas or sporadic case reports. 
Because they are uncommon, adnexal lymphomas can 
be difficult to diagnose and manage(3).
Because of the clinical presentation and the multino-
dular and ulcerative aspects of our patient’s lesion, the 
differential diagnosis considered epidermoid carcinoma, 
Merkel cell carcinoma, sebaceous cell carcinoma, and 
even metastasis. Her previous history of anaplastic large 
cell primary cutaneous lymphoma suggested the possi-
bility of a lymphoid tumor.
Figure 1. The multinodular lesion in the patient’s upper eyelid, with ulce-
ration and secondary hyperkeratosis.
Figure 2. Ulcerative lesions on the patient’s lower limb.
Figure 3. Incisional biopsy, showing pseudoepitheliomatous epidermal 
hyperplasia and giant atypical cells with dermic tumoral infiltrate.
Figure 4. The eyelid after systemic chemotherapy, showing complete 
re gression of the lesion.
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CD30+ anaplastic large cell primary cutaneous lym-
phomas typically present in elderly patients as ulcerated 
solitary nodules on the limbs, with over 20% being multi-
focal. Eyelid involvement in a anaplastic large cell primary 
cutaneous lymphoma is rare and usually appears seconda-
ry to systemic anaplastic large cell lymphoma. Even though 
eyelid involvement by primary cutaneous anaplastic large 
cell lymphoma, as shown in our clinical case, presents ra-
rely, there have been previous reports of this(1,2,4).
The mean survival rate after 5 years is 90%, but relap-
ses are frequent, so strict follow-up of this patient group 
is essential. Extracutaneous dissemination, particularly to 
regional lymph nodes, occurs in approximately 10% of 
cases(5). A variant of keratoacanthoma-like cutaneous 
anaplastic large cell lymphoma has been described(6,7); this 
could have been a diagnostic option for our case, given that 
these lesions are prone to ulceration and hyperkeratosis.
The definitive diagnosis is made anatomopathologi-
cally, especially for lymphoid tumors, where immuno-
histochemistry is essential. A differential diagnosis that 
includes other CD30+ lymphoproliferative disorders, 
especially anaplastic large cell lymphoma with secon-
dary cutaneous involvement, is fundamental. A systemic 
workout is essential; although the lesions are similar, the 
prognosis and therapeutic approach differ significantly.
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